| Mrs Angela Lynn Titus, FNP-BC | |
|
172 Linden Dr Ste 107, Winchester, VA 22601-2892 | |
| (540) 678-0767 | |
| (540) 678-0769 |
| Full Name | Mrs Angela Lynn Titus |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 172 Linden Dr Ste 107, Winchester, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093072225 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QH0002X | Family Medicine - Hospice And Palliative Medicine | 0001154919 (Virginia) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 0024170012 (Virginia) | Primary |
| Entity Name | Urology Associates Of Winchester Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275571705 PECOS PAC ID: 2264415074 Enrollment ID: O20040611000916 |
News Archive
With health care reform efforts ramping up after the summer break, many of the nation's employers are focusing on the action in Congress and plan to adjust their benefit strategies based on how final legislation affects their costs, according to a survey of 433 HR and benefit executives from midsize and large organizations conducted by professional services firm Towers Perrin.
Scientists have identified the key molecular pathway leading to depression, revealing potential new targets for drug discovery, according to research led by King's College London's Institute of Psychiatry. The study, published today in Neuropsychopharmacology, reveals for the first time that the 'Hedgehog pathway' regulates how stress hormones, usually elevated during depression, reduce the number of brain cells.
LDR, a privately held medical device company offering innovative spinal implants for both non-fusion and fusion applications, announced the March 11 submission of its two-level Mobi-C cervical artificial disc PMA to the FDA. LDR is one of only two companies to have completed a two-level randomized IDE trial with two-year follow up, and is the first to submit its results.
Liberator Medical Holdings, Inc. today pre-announces record net revenues of approximately $7.7 million for its fiscal fourth quarter ended September 30, 2009, representing an annualized revenue run rate of over $30.0 million.
› Verified 3 days ago
| Entity Name | Winchester Endocrinology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215034798 PECOS PAC ID: 1557464898 Enrollment ID: O20070307000324 |
News Archive
With health care reform efforts ramping up after the summer break, many of the nation's employers are focusing on the action in Congress and plan to adjust their benefit strategies based on how final legislation affects their costs, according to a survey of 433 HR and benefit executives from midsize and large organizations conducted by professional services firm Towers Perrin.
Scientists have identified the key molecular pathway leading to depression, revealing potential new targets for drug discovery, according to research led by King's College London's Institute of Psychiatry. The study, published today in Neuropsychopharmacology, reveals for the first time that the 'Hedgehog pathway' regulates how stress hormones, usually elevated during depression, reduce the number of brain cells.
LDR, a privately held medical device company offering innovative spinal implants for both non-fusion and fusion applications, announced the March 11 submission of its two-level Mobi-C cervical artificial disc PMA to the FDA. LDR is one of only two companies to have completed a two-level randomized IDE trial with two-year follow up, and is the first to submit its results.
Liberator Medical Holdings, Inc. today pre-announces record net revenues of approximately $7.7 million for its fiscal fourth quarter ended September 30, 2009, representing an annualized revenue run rate of over $30.0 million.
› Verified 3 days ago
| Entity Name | Valley Physician Enterprise Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538316203 PECOS PAC ID: 9931268091 Enrollment ID: O20081104000278 |
News Archive
With health care reform efforts ramping up after the summer break, many of the nation's employers are focusing on the action in Congress and plan to adjust their benefit strategies based on how final legislation affects their costs, according to a survey of 433 HR and benefit executives from midsize and large organizations conducted by professional services firm Towers Perrin.
Scientists have identified the key molecular pathway leading to depression, revealing potential new targets for drug discovery, according to research led by King's College London's Institute of Psychiatry. The study, published today in Neuropsychopharmacology, reveals for the first time that the 'Hedgehog pathway' regulates how stress hormones, usually elevated during depression, reduce the number of brain cells.
LDR, a privately held medical device company offering innovative spinal implants for both non-fusion and fusion applications, announced the March 11 submission of its two-level Mobi-C cervical artificial disc PMA to the FDA. LDR is one of only two companies to have completed a two-level randomized IDE trial with two-year follow up, and is the first to submit its results.
Liberator Medical Holdings, Inc. today pre-announces record net revenues of approximately $7.7 million for its fiscal fourth quarter ended September 30, 2009, representing an annualized revenue run rate of over $30.0 million.
› Verified 3 days ago
| Entity Name | Privia Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013042480 PECOS PAC ID: 4385682061 Enrollment ID: O20140603000011 |
News Archive
With health care reform efforts ramping up after the summer break, many of the nation's employers are focusing on the action in Congress and plan to adjust their benefit strategies based on how final legislation affects their costs, according to a survey of 433 HR and benefit executives from midsize and large organizations conducted by professional services firm Towers Perrin.
Scientists have identified the key molecular pathway leading to depression, revealing potential new targets for drug discovery, according to research led by King's College London's Institute of Psychiatry. The study, published today in Neuropsychopharmacology, reveals for the first time that the 'Hedgehog pathway' regulates how stress hormones, usually elevated during depression, reduce the number of brain cells.
LDR, a privately held medical device company offering innovative spinal implants for both non-fusion and fusion applications, announced the March 11 submission of its two-level Mobi-C cervical artificial disc PMA to the FDA. LDR is one of only two companies to have completed a two-level randomized IDE trial with two-year follow up, and is the first to submit its results.
Liberator Medical Holdings, Inc. today pre-announces record net revenues of approximately $7.7 million for its fiscal fourth quarter ended September 30, 2009, representing an annualized revenue run rate of over $30.0 million.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Angela Lynn Titus, FNP-BC 172 Linden Dr Ste 107, Winchester, VA 22601-2892 Ph: (540) 678-0767 | Mrs Angela Lynn Titus, FNP-BC 172 Linden Dr Ste 107, Winchester, VA 22601-2892 Ph: (540) 678-0767 |
News Archive
With health care reform efforts ramping up after the summer break, many of the nation's employers are focusing on the action in Congress and plan to adjust their benefit strategies based on how final legislation affects their costs, according to a survey of 433 HR and benefit executives from midsize and large organizations conducted by professional services firm Towers Perrin.
Scientists have identified the key molecular pathway leading to depression, revealing potential new targets for drug discovery, according to research led by King's College London's Institute of Psychiatry. The study, published today in Neuropsychopharmacology, reveals for the first time that the 'Hedgehog pathway' regulates how stress hormones, usually elevated during depression, reduce the number of brain cells.
LDR, a privately held medical device company offering innovative spinal implants for both non-fusion and fusion applications, announced the March 11 submission of its two-level Mobi-C cervical artificial disc PMA to the FDA. LDR is one of only two companies to have completed a two-level randomized IDE trial with two-year follow up, and is the first to submit its results.
Liberator Medical Holdings, Inc. today pre-announces record net revenues of approximately $7.7 million for its fiscal fourth quarter ended September 30, 2009, representing an annualized revenue run rate of over $30.0 million.
› Verified 3 days ago